HEPION PHARMACEUTICALS, INC. Accounts Payable
HEPION PHARMACEUTICALS, INC. (HEPA) had Accounts Payable of $169.88 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $169.88K.
- 2026-03-31: Accounts Payable, Current $138.44K.
- 2025-12-31: Accounts Payable, Current $167.81K.
- 2025-09-30: Accounts Payable, Current $77.24K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $169.88K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $138.44K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $167.81K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $77.24K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $172.70K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $243.26K 10-Q · filed 2025-05-19 |
| 2024-12-31 | $220.20K 10-K · filed 2026-03-12 |
| 2024-09-30 | $186.26K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $446.54K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-21 |
| 2023-12-31 | $2.35M 10-K · filed 2025-04-08 |
| 2023-09-30 | $3.01M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $4.19M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.17M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.67M 10-K · filed 2024-04-16 |
| 2022-09-30 | $2.63M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.91M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.38M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.45M 10-K · filed 2023-04-10 |
| 2021-09-30 | $1.79M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.09M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.66M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.72M 10-K · filed 2022-04-08 |
| 2020-09-30 | $1.30M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $972.36K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $850.07K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $491.56K 10-K · filed 2021-03-31 |
| 2019-09-30 | $675.47K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $282.59K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $706.60K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $748.43K 10-K · filed 2020-05-14 |
| 2018-09-30 | $2.22M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.08M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.73M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.56M 10-K · filed 2019-03-14 |
| 2017-09-30 | $1.48M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.63M 10-KT · filed 2018-03-26 |
| 2017-03-31 | $1.56M 10-Q · filed 2017-04-12 |
| 2016-12-31 | $2.30M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $4.40M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $4.25M 10-KT · filed 2018-03-26 |
| 2016-03-31 | $3.44M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $3.16M 10-Q · filed 2016-02-12 |
| 2015-09-30 | $3.20M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.48M 10-K · filed 2016-09-28 |
| 2015-03-31 | $1.31M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $114.41K 10-Q · filed 2015-02-12 |
| 2014-09-30 | $213.33K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $243.90K 10-K · filed 2015-09-25 |
| 2014-03-31 | $187.72K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $55.51K 10-Q · filed 2014-02-05 |
| 2013-09-30 | $28.01K 10-Q · filed 2013-11-19 |
| 2013-06-30 | $3.62K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |